21 West Wealth Management’s AbbVie ABBV Stock Holding History

21 West Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Hold	1,260	–	–	0.27%	57
2026 Q1	$274K	Sell	1,260 -4	-0.3%	-$887	0.25%	55
2025 Q4	$289K	Hold	1,264	–	–	0.26%	53
2025 Q3	$293K	Sell	1,264 -25	-2%	-$5.09K	0.28%	53
2025 Q2	$239K	Buy	+1,289	New	+$240K	0.24%	57

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

21 West Wealth Management's ABBV Position: Q2 2026 in Review

21 West Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,260 shares worth $317K. The position accounts for 0.27% of the portfolio, ranked #57.

21 West Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 928 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

21 West Wealth Management held 1,260 shares of AbbVie worth $317K as of Q2 2026.
21 West Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.27% of 21 West Wealth Management's portfolio in Q2 2026, its #57 holding.
21 West Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
928 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 21 West Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.